SCHEMBL19610481

SCHEMBL19610481

CC(C)c1cc(-c2cc(C(C)C)c(C(=O)O)c(C(C)C)c2)cc(C(C)C)c1C(=O)O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 1/20 0.72
FABP4 P15090 1/20 0.72
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
LDHA P00338 2/20 0.40
LDHB P07195 2/20 0.40
SRD5A2 P31213 1/20 0.40
ACE2 Q9BYF1 2/20 0.38
GABRA1 P14867 1/20 0.37
GABRB1 P18505 1/20 0.37
ALB P02768 3/20 0.37
EIF4A3 P38919 2/20 0.36
GAA P10253 1/20 0.35
HCAR3 P49019 1/20 0.35
HCAR2 Q8TDS4 1/20 0.35
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
CYP3A4 P08684 1/20 0.34
ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17935194 0.92 CA1 (0.68) FABP3FABP4CA1CA2LDHA
SCHEMBL28708940 0.90 FABP3 (0.78) FABP3FABP4CA1CA2LDHA
SCHEMBL810177 0.84 FABP3 (1.00) FABP3FABP4LDHALDHBACE2
SCHEMBL14273020 0.84 FABP3 (0.69) FABP3FABP4CA1CA2LDHA
SCHEMBL17323547 0.84 FABP3 (0.69) FABP3FABP4LDHALDHBACE2
SCHEMBL17311830 0.82 FABP3 (0.96) FABP3FABP4LDHALDHBACE2
SCHEMBL10360591 0.80 FABP3 (0.64) FABP3FABP4LDHALDHBACE2
SCHEMBL9857114 0.80 FABP3 (0.49) FABP3FABP4CA1CA2GABRA1
SCHEMBL19164751 0.79 FABP3 (0.63) FABP3FABP4CA1CA2LDHA
SCHEMBL6637397 0.76 FABP3 (0.59) FABP3FABP4CA1CA2GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329243-B2 Biphenyl derivative and uses thereof XI'AN LIBANG PHARMACEUTICAL CO., LTD (CN) 2019-06-25 US disclosed
US-20180141895-A1 DIPHENYL DERIVATIVE AND USES THEREOF XI'AN LIBANG PHARMACEUTICAL CO., LTD (CN) 2018-05-24 US disclosed
EP-3246304-A2 DIPHENYL DERIVATIVE AND USES THEREOF Xi'an Libang Pharmaceutical Co., Ltd (CN) 2017-11-22 EP disclosed
CN-104557532-B Bigeminy benzene derivative and its application 西安力邦制药有限公司 2017-03-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329243-B2 Biphenyl derivative and uses thereof PPARD, PCSK9, UGT2B7 FABP3 15/4885FABP4 258/4885CA1 2711/4885
US-20180141895-A1 DIPHENYL DERIVATIVE AND USES THEREOF PPARD, DPP3, DPP7 FABP3 46/4885FABP4 629/4885CA1 2497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.